Serina Therapeutics appoints Trevi CCO Farrell Simon to board

SERA•2026-07-22

Board appointment effective immediately

Serina Therapeutics named Farrell Simon to its board, effective immediately.

Simon will join the audit committee, plus the compensation committee.

Background at Trevi Therapeutics and Pfizer

Simon is chief commercial officer at Trevi Therapeutics, leading commercial strategy, lifecycle management, pre-launch planning, business development.

Previously held senior commercial, strategic leadership roles at Pfizer, including Biopharma chief of staff.

Serina Therapeutics appoints Trevi CCO Farrell Simon to board

Board appointment effective immediately

Background at Trevi Therapeutics and Pfizer

Related News

Las Vegas Sands falls after missing quarterly estimates

Five Below says cyber incident on employee computer contained, no material impact expected

Franklin Municipal Opportunities Trust - Fund May Offer Common Shares From Time To Time In Multiple Offerings - SEC Filing

Shutterstock - Steven Ciardiello To Resign As Chief Accounting Officer - SEC Filing

IBM lifts FY revenue growth outlook to 4%-5% at constant currency